﻿<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<?xml-stylesheet type="text/xsl" href="/css/apdocuments/ap-case.xsl"?>
<apCase>
  <creationDate>2020-08-19</creationDate>
  <apCaseHeader>
    <fileNumbers>
      <fileNumber>3-19318</fileNumber>
    </fileNumbers>
    <respondents>
      <respondent>BCI Holding Inc.</respondent>
      <respondent>Bulova Technologies Group, Inc.</respondent>
      <respondent>Omni Bio Pharmaceutical, Inc.</respondent>
    </respondents>
    <caseLink>/litigation/apdocuments/ap-3-19318.xml</caseLink>
  </apCaseHeader>
  <releaseItem>
    <date>2019-08-06</date>
    <releaseNumber>34-86584</releaseNumber>
    <otherReleaseNumbers />
    <title>Order Instituting Administrative Proceedings and Notice of Hearing Pursuant to Section 12(j) of the Securities Exchange Act of 1934</title>
    <secLink>/litigation/admin/2019/34-86584.pdf</secLink>
  </releaseItem>
  <releaseItem>
    <date>2019-10-01</date>
    <releaseNumber></releaseNumber>
    <otherReleaseNumbers />
    <title>Division of Enforcement's Motion for Default and Brief in Support </title>
    <secLink>/litigation/apdocuments/3-19318-event-4.pdf</secLink>
  </releaseItem>
  <releaseItem>
    <date>2020-01-29</date>
    <releaseNumber>34-88086</releaseNumber>
    <otherReleaseNumbers />
    <title>Order to Show Cause</title>
    <secLink>/litigation/opinions/2020/34-88086.pdf</secLink>
  </releaseItem>
  <releaseItem>
    <date>2020-08-18</date>
    <releaseNumber>34-89606</releaseNumber>
    <otherReleaseNumbers />
    <title>Opinion of the Commission</title>
    <secLink>/litigation/opinions/2020/34-89606.pdf</secLink>
  </releaseItem>
</apCase>